SB
Sunshine Biopharma, Inc.
SBFM · NASDAQ
$0.90 +9.73% (+$0.08)
1M -22.43%
Market Cap $2.00M
P/E Ratio -
Div. Yield -
ROE 24.23%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.07x
P/S 0.06x
P/FFO N/A
Growth
86 /100
Growing Book val. growth 2.13%
Rev. growth 102.91%
FCF growth N/A
Profitability
11 /100
Weak Net margin 16.50%
Op. margin 14.71%
FCF margin 13.01%
Quality
13 /100
Poor ROE 24.23%
ROA 17.34%
Asset turnover 1.05x
Debt
100 /100
Low Current ratio 5.46x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Rev. volatility 249.09%
EPS volatility 8.81%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SBFM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Steve N. Slilaty
Employees
50
Headquarters
Fort Lauderdale
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report